tiprankstipranks
Protara Therapeutics (TARA)
NASDAQ:TARA
US Market
TARA
Protara Therapeutics
RESEARCH TOOLSreports
Want to see TARA full AI Analyst Report?

Protara Therapeutics (TARA) Financial Statements

1,396 Followers

Protara Therapeutics Financial Overview

Protara Therapeutics's market cap is currently $288.27M. The company's EPS TTM is $; its P/E ratio is -3.97; Protara Therapeutics is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -362.00K$ 0.00$ -341.00K$ 0.00$ 0.00
Operating Income$ -64.55M$ -49.15M$ -43.61M$ -67.06M$ -47.49M
EBITDA$ -64.19M$ -48.82M$ -43.27M$ -64.57M$ -45.40M
Net Income$ -57.44M$ -44.60M$ -40.42M$ -65.95M$ -47.25M
Balance Sheet
Cash & Short-Term Investments$ 155.55M$ 170.29M$ 65.58M$ 84.37M$ 91.23M
Total Assets$ 209.47M$ 181.45M$ 78.95M$ 113.29M$ 172.60M
Total Debt$ 3.36M$ 4.48M$ 5.47M$ 6.38M$ 7.24M
Net Debt$ -46.30M$ -158.31M$ -34.12M$ -17.74M$ -28.48M
Total Liabilities$ 13.06M$ 14.32M$ 10.63M$ 11.21M$ 10.68M
Stockholders' Equity$ 196.41M$ 167.13M$ 68.32M$ 102.08M$ 161.91M
Cash Flow
Free Cash Flow$ -56.46M$ -35.87M$ -37.60M$ -26.58M$ -35.10M
Operating Cash Flow$ -56.37M$ -35.81M$ -37.56M$ -26.46M$ -34.50M
Investing Cash Flow$ -139.49M$ 19.16M$ 53.11M$ 14.95M$ -98.19M
Financing Cash Flow$ 82.72M$ 139.87M$ -91.00K$ -90.00K$ -228.00K
Currency in USD

Protara Therapeutics Earnings and Revenue History

Income Statement >

Protara Therapeutics Debt to Assets

Balance Sheet >

Protara Therapeutics Cash Flow

Cash Flow >

Protara Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >